CUE Cue Biopharma
Company Analysis
Latest News
🔴 Cue Biopharma is trading 12% down today despite biotechnology strength
Cue Biopharma is trading 11.95% down at $25.04, with no clear company-specific catalyst identified for September 2, 2026. - Investor relations’ latest listed...
🔴 Cue Biopharma is trading 7% down today with no clear company-specific catalyst
Cue Biopharma is trading 7.24% down now at $26.38 after no clear company-specific catalyst was identified for September 2, 2026. - The latest company release,...
🟢 Cue Biopharma is trading 11.4% up today with no clear catalyst identified
Cue Biopharma is trading 11.4% up at $28.43, with no clear company-specific catalyst identified for September 1, 2026. - The move follows an 8.46% decline on...
🟢 Cue Biopharma is trading 5.31% up today with no clear catalyst identified
Cue Biopharma is trading 5.31% up at $26.88, rebounding after its 8.46% decline on August 31, 2026, with no new company-specific announcement or clearly...
🔴 Cue Biopharma is trading 6.35% down today with no new company-specific catalyst identified
Cue Biopharma is trading 6.35% down at $26.11, with no new company-specific catalyst identified for August 31, 2026. - The decline follows a sharp late-August...
🟢 Cue Biopharma is trading 5.65% up today — no clear catalyst identified
Cue Biopharma is trading 5.65% up now at $29.75 after a sharp multi-session advance, with no clear catalyst identified. - Shares gained 15.44% on August 25...
🔴 Cue Biopharma is trading 7.04% down today after reversing sharply from recent gains
Cue Biopharma is trading 7.04% down at $26.82 after reversing sharply from recent gains. - The stock rose 15.44% on August 25 and 7.81% on August 26 before...
🟢 Cue Biopharma is trading 5% up in pre-market on continued biotech-sector momentum
Cue Biopharma is trading 5.09% up now at $30.32, after extending gains from August 25 and August 26, with continued biotechnology-sector momentum cited as the...
🟢 Cue Biopharma is trading 5.9% up today on biotech-sector momentum
Cue Biopharma is trading 5.9% up now at $28.34, with continued biotechnology-sector momentum the strongest identified driver; XBI rose 2.06% during regular...
🟢 Cue Biopharma is trading 11.22% up today as XBI gains 2.06%
Cue Biopharma is trading 11.22% up at $25.78, with biotech-sector strength providing the primary support amid broader risk-on sentiment. - XBI is up 2.06%...
🟢 Cue Biopharma is trading 7.81% up today as biotech strength supports gains
Cue Biopharma is trading at $24.99, up 7.81%, supported primarily by biotech-sector strength. - Shares rebounded after falling from $34.20 on August 14 to...
🔴 Cue Biopharma is trading 5% down today after Purcell & Lefkowitz announced shareholder investigation
Cue Biopharma is trading at $22.77 (-5.05%) after Purcell & Lefkowitz announced a shareholder investigation into recent corporate actions. - Wall Street Zen...
Cue Biopharma Downgraded to Sell, Following Massive $24.14 Per Share Loss
Wall Street Zen downgraded Cue Biopharma (NASDAQ:CUE) from hold to sell on Sunday. This action contributes to a consensus sell rating for the company. The...
🔴 Cue Biopharma is trading 5.2% down today
Cue Biopharma is trading 5.2% down at $23.32 after reversing an early pre-market rebound. - No clear company-specific announcement was identified for August...
🟢 Cue Biopharma is trading 5.57% up in pre-market amid broader risk-on rebound
Cue Biopharma is trading 5.57% up in pre-market at $25.98, appearing to reflect broader pre-market risk appetite after the previous session’s selloff. -...
🔴 Cue Biopharma falls 5.0% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Cue Biopharma is trading 6.9% up today amid continued reaction to Q2 results
Cue Biopharma is trading 6.9% up at $28.08, continuing a volatile reaction to its August 14, 2026 second-quarter results and recent pipeline developments. -...
🟢 Cue Biopharma is trading 5% up in after-hours trading after earnings and a two-session slide
Cue Biopharma is trading 5.06% up in after-hours trading at $27.00, appearing to reflect continued post-earnings volatility and a rebound after two consecutive...
🔴 Cue Biopharma is trading 10% down today after senior executives sold substantial shareholdings
Cue Biopharma is trading 9.99% down at $24.88 after an August 18 disclosure that senior executives sold substantial shareholdings. - The legal chief sold...
Cue Biopharma's $153 Million Loss Dwarfs Revenue Gains — Can One-Time Charges Excuse the Sticker Shock?
Shares of Cue Biopharma plunged 13.7% to $29.53 as investors digested a second-quarter loss so large it made the company's genuine revenue progress almost...